1. In Vivo

UK, Sweden Test Differing Antibiotic Market Models

But Both Seek Reward Mechanisms That Assure National Antibiotic Supplies

 
• By Sten Stovall

Sweden and the UK are conducting differing ‘develop and test’ programs to assess so-called ‘pull’ incentives in which an antibiotics innovator will be paid an annual fee in return for an access guarantee for anti-infectives. The projects have drawn keen attention from other countries. 

World map

One key difference between the new incentives programs being trialed by the UK and Sweden is that the UK approach is focused on paying for the added value of a new antimicrobial by delinking volume of sales from reimbursement, with the aim of incentivising the research and development of new antibiotics. The Swedish program is aimed at ensuring the availability of already approved and existing antibiotics to the Swedish health system. Another key difference is the Swedish program does not involve a health technology assessment of any new antibiotics, whereas the British approach does.

The two programs do share the goal of finding ways to maintain a secure access to effective antibiotics at justifiable...

More from Market Access

More from In Vivo

Podcast: ADDF’s Karen Harris On Investing In Alzheimer’s Like A VC

 
• By David Wild

A discussion with Karen Harris, CFO of the Alzheimer's Drug Discovery Foundation, about the foundation's investment strategy, biotech and investor sentiment at the recent BIO conference and what innovations give her hope for Alzheimer's patients.

Turning Defense Into Attack: Snapshots Of A Changing Medtech Market And How To Respond

 
• By Ashley Yeo

Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.

AI Agents Set To Reshape Biopharma’s Workforce And Operations

 
• By David Wild

While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.